BioProcess International is part of the Informa Connect Division of Informa PLC
Informa PLC
|
ABOUT US
|
INVESTOR RELATIONS
|
TALENT
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
BPI Events
About
Subscribe
Contribute
Subscribe
Subscribe
Upstream
Related Topics
Bioreactors
Expression Platforms
Biochemicals/Raw Materials
Cell Culture Media
Microbial Cell Culture
Perfusion Cell Culture
Recent in
Upstream
See all
turbulent flow image
Bioreactors
Lessons in Bioreactor Scale-Up, Part 2: A Refresher on Fluid Flow and Mixing
Lessons in Bioreactor Scale-Up, Part 2: A Refresher on Fluid Flow and Mixing
by
Muhammad Arshad Chaudhry
Jun 12, 2024
Downstream
Related Topics
Filtration
Viral Clearance
Separation/Purification
Chromatography
Recent in
Downstream
See all
Thermo Fisher/AstraZeneca webinar title slide
Chromatography
Manufacturing Friendly Aggregate Clearance in Downstream Processing of Bispecific and Traditional Antibodies Using a Novel POROs Mixed-Mode Chromatography Media
Manufacturing Friendly Aggregate Clearance in Downstream Processing of Bispecific and Traditional Antibodies Using a Novel POROs Mixed-Mode Chromatography Media
by
BPI Contributor
Jun 6, 2024
30 Min View
Manufacturing
Related Topics
Biosimilars
Continuous Bioprocessing
Facility Design/Engineering
Formulation
Single Use
Fill/Finish
Information Technology
Recent in
Manufacturing
See all
thumbnail
Bioprocess Insider
KBI extends pharma contract with a $250m purchasing commitment
KBI extends pharma contract with a $250m purchasing commitment
by
Josh Abbott
Jul 25, 2024
2 Min Read
thumbnail
Bioprocess Insider
Alcami expands storage capacity at new RTP location
Alcami expands storage capacity at new RTP location
by
Josh Abbott
Jul 25, 2024
2 Min Read
Analytical
Related Topics
QA/QC
Cell Line Development
PAT
Product Characterization
Bioanalytical Methods
Process Development
Assays
Recent in
Analytical
See all
PRI/HCP eBook cover wide
Process Development
eBook: Host Cell Proteins — Moving from Detection to Knowledge-Building
eBook: Host Cell Proteins — Moving from Detection to Knowledge-Building
by
Derrick Zhang,
Shankar Sellappan
and 3 more
Jul 26, 2024
hand cleaning equipment
QA/QC
Extending the Visible Residue Limit Approach to Potent Therapeutic Proteins — Part 2: Test Results and Conclusions
Extending the Visible Residue Limit Approach to Potent Therapeutic Proteins — Part 2: Test Results and Conclusions
by
Ram Kouda,
Syeda Tabassum
and 3 more
Jun 12, 2024
Business
Related Topics
Bioregions
Careers & Training
Contract Services
Economics
Pre-Clinical & Clinical Trials
Risk Management
Intellectual Property
Regulatory Affairs
Recent in
Business
See all
Resilience logo
Sponsored Content
Built to Serve Innovation: A Briefing on Commercial Readiness at Resilience
Built to Serve Innovation: A Briefing on Commercial Readiness at Resilience
by
BPI Contributor
Jun 25, 2024
15 Min View
scientist at computer
Bioregions
US–India Collaborative Innovations for Rapid Drug Discovery
US–India Collaborative Innovations for Rapid Drug Discovery
by
Jitendra Kumar
Jun 12, 2024
Therapeutic Modalities
Related Topics
Cell Therapies
Gene Therapies
MAb
Emerging Therapeutics
Personalized Medicine
Large Molecule Development
Vaccines
Recent in
Therapeutic Modalities
See all
thumbnail
Bioprocess Insider
Biomanufacturing in space accelerating therapy development on Earth
Biomanufacturing in space accelerating therapy development on Earth
by
Josh Abbott
Jul 24, 2024
3 Min Read
iStock photo
Cell Therapies
Analytical Considerations for Gene-Modified Hematopoietic Stem and Progenitor Cell Therapies: Part 2 — Starting Materials and Drug Substances
Analytical Considerations for Gene-Modified Hematopoietic Stem and Progenitor Cell Therapies: Part 2 — Starting Materials and Drug Substances
by
Brent Morse,
Alicja Fiedorowicz
Jun 19, 2024
BioProcess Insider
Related Topics
Deal-Making
Facilities & Capacity
Global Markets
Regulations
Therapeutic Class
Upstream & Downstream Processing
Webcasts
BioProcess Insider Podcasts
Recent in
BioProcess Insider
See all
thumbnail
Global Markets
US BIOSECURE Act: Navigating challenges and opportunities
US BIOSECURE Act: Navigating challenges and opportunities
by
Shreeyashi Ojha
Jul 26, 2024
2 Min Read
thumbnail
Bioprocess Insider
KBI extends pharma contract with a $250m purchasing commitment
KBI extends pharma contract with a $250m purchasing commitment
by
Josh Abbott
Jul 25, 2024
2 Min Read
Home
Carlos Eduardo Espinosa-de la Garza
Carlos Eduardo Espinosa-de la Garza
Latest from Carlos Eduardo Espinosa-de la Garza
Opportunities in the Field of Host Cell Proteins — Part 4: The Future of Immunogenicity Prediction
QA/QC
Opportunities in the Field of Host Cell Proteins — Part 4: The Future of Immunogenicity Prediction
Opportunities in the Field of Host Cell Proteins — Part 4: The Future of Immunogenicity Prediction
by
Víctor Pérez Medina Martínez,
Carlos Eduardo Espinosa-de la Garza
and 1 more
Feb 9, 2023
Opportunities in the Field of Host Cell Proteins Part 3: Case Studies in Impurity Detection and Identification
Separation/Purification
Opportunities in the Field of Host Cell Proteins Part 3: Case Studies in Impurity Detection and Identification
Opportunities in the Field of Host Cell Proteins Part 3: Case Studies in Impurity Detection and Identification
by
Víctor Pérez Medina Martínez,
Carlos Eduardo Espinosa-de la Garza
and 1 more
Dec 6, 2022
All from Carlos Eduardo Espinosa-de la Garza
Separation/Purification
Opportunities in the Field of Host Cell Proteins: Part 2: Ensuring Patient Safety
Opportunities in the Field of Host Cell Proteins: Part 2: Ensuring Patient Safety
Oct 20, 2022